Post Profile






See more about: Threshold Pharmaceuticals

Related Posts


Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)

Business & Finance / Investing : Insider Monkey

Is it smart to be bullish on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)? At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading senti...

A Late-Stage Threshold Pharmaceuticals, Inc. (THLD) for Success?

Business & Finance / Investing : Insider Monkey

Shares of Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) popped nearly 8% in early trading today on the phase 3 initiation announcement for pancreatic cancer drug TH-302. While a licensing agreement put the trial financials in Merck ...

Threshold Pharmaceuticals, Inc. (THLD): A Biotech That Investors Need To Know About

Business & Finance / Investing : Insider Monkey

Biotech stocks can provide astronomical returns but also depressing losses. Before investing in these volatile stocks, investors need to understand the full picture, including fundamentals, technical, and upcoming catalysts. Below a...

Threshold Pharmaceuticals, Inc. (THLD): Hedge Funds and Insiders Are Bearish, What Should You Do?

Business & Finance / Investing : Insider Monkey

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) has experienced a decrease in activity from the world’s largest hedge funds of late. According to most investors, hedge funds are perceived as slow, outdated investment vehicles of years...

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD): Are Hedge Funds Right About This Stock?

Business & Finance / Investing : Insider Monkey

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) was in 14 hedge funds’ portfolio at the end of the fourth quarter of 2012. THLD investors should pay attention to a decrease in hedge fund interest in recent months. There were 14 hedge ...

Comments


Copyright © 2016 Regator, LLC